Keeping Up the Pace in IBD: Adaptive Learning to Optimize Therapeutic Decision-Making for Patients with UC and CD

CME: 3.0

Target Audience

This activity is intended for IBD specialists, general gastroenterologists, and NPs and PAs who manage patients with IBD.

Program Overview

Whether you’re a specialist looking for advanced-level learning around optimally managing Crohn’s disease and ulcerative colitis, a generalist needing to expand your knowledge of inflammatory bowel disease (IBD), or an allied healthcare professional wanting to support patients, don’t miss the opportunity to participate in this one-of-a-kind educational experience. In this adaptive learning activity, experience education uniquely tailored to your individual needs.

Management of ulcerative colitis and Crohn’s disease is complicated due to their complex pathophysiology. As evidence continues to build and guide treatment paradigms, clinicians need to be aware of the new and emerging treatment options and skilled in the art of tailoring therapy to an individual patient’s needs, ongoing symptoms, and quality of life (QoL). In this dynamic platform, learners engage in questions across multiple topics to access insights through current data, key takeaways, and expert guidance, in order to optimize treatment of these chronic autoimmune disorders.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Outline the importance of optimizing quality of life for patients with IBD
  • Assess the clinical data and potential roles of IBD therapies recently approved and in late-stage development
  • Differentiate newer IBD therapies from the older, conventional agents
  • Incorporate treat to target (T2T) strategies into the management of patients with IBD
  • Review the latest evidence with novel biomarkers for IBD care

Post a comment to this article